Net Cash Provided by (Used in) Operating Activities |
-199 K |
USD |
+70.9% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
460 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
157 M |
USD |
|
Dec 31, 2023 |
2023 |
Common Stock, Shares Authorized |
100 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
4.76 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-459 K |
USD |
-253% |
Dec 31, 2023 |
2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
477 K |
USD |
+482% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
357 K |
USD |
+184% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
357 K |
USD |
+184% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-231 K |
USD |
-83.8% |
Dec 31, 2023 |
2023 |
Preferred Stock, Shares Authorized |
1 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
10.5 K |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Current Federal Tax Expense (Benefit) |
1.14 M |
USD |
+134% |
Dec 31, 2023 |
2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |